Company news
Wave Life Sciences Ltd. news in 2019
Wave Life Sciences Ltd.'s news releases, calls and decks from 2019, newest first.
Wave Life Sciences Announces Topline Data and Addition of Higher Dose Cohort in Ongoing Phase 1b/2a PRECISION-HD2 Trial in Huntington’s Disease
December 29, 2019
Wave Life Sciences Announces Discontinuation of Suvodirsen Development for Duchenne Muscular Dystrophy
December 15, 2019
Wave Life Sciences Reports Third Quarter 2019 Financial Results and Provides Business Update
November 4, 2019
Wave Life Sciences Announces Fast Track Designation from U.S. FDA for Suvodirsen
September 15, 2019
Decks in 2019
- Technical Presentation (December 2019)
Technical · 19 slides · Dec 30, 2019
- Investor Presentation (December 2019)
Investor deck · 40 slides · Dec 16, 2019
- Investor Presentation (November 2019)
Investor deck · 58 slides · Nov 5, 2019
- Investor Day (October 2019)
Investor day · 63 slides · Oct 7, 2019
- Investor Presentation (July 2019)
Investor deck · 42 slides · Jul 29, 2019
- Investor Presentation (June 2019)
Investor deck · 42 slides · Jun 5, 2019
- Investor Presentation (May 2019)
Investor deck · 39 slides · May 10, 2019
- Muscular Dystrophy Association Clinical and Scientific Conference 2019
Conference · 25 slides · Apr 16, 2019
- Investor Presentation (March 2019)
Investor deck · 43 slides · Mar 1, 2019
- Investor Presentation (January 2019)
Investor deck · 44 slides · Jan 3, 2019